论文部分内容阅读
Objective Neoadjuvant chemotherapy(NACT)have been employed to improve the survival rate for cancer patients.And nowadays,most RCT(randomized control trial)focus on the long-term effects that patients can benefit from NACT rather than the side effects it brings in the short term.